Form 4: USANA Health Sciences Director Exercises Stock Options
SEC Form 4 Filing
Frederic J. Winssinger, a director at USANA Health Sciences, executed a transaction involving restricted stock units, resulting in the acquisition and disposal of common stock.
Summary
- On November 2, 2024, Frederic J. Winssinger, a director of USANA Health Sciences Inc., engaged in a transaction involving restricted stock units.
- Winssinger exercised 675 restricted stock units, which converted into 675 shares of USNA common stock.
- Following the transaction, Winssinger directly owns 4,523 shares of common stock and 1,348 restricted stock units.
- The restricted stock units vest in four tranches: August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports a routine transaction by a company director.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the actions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| August 2, 2024 | 25% of Restricted Stock Units vest |
| November 2, 2024 | Transaction date: Director exercised restricted stock units; 25% of Restricted Stock Units vest |
| February 2, 2025 | 25% of Restricted Stock Units vest |
| May 2, 2025 | 25% of Restricted Stock Units vest |
| November 5, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.